Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
The U.S. Food and Drug Administration (FDA) continues to advance its Real-World Evidence (RWE) Program, designed ...
In the high-stakes world of pharmaceuticals and life sciences, regulatory submissions are the final gateway ...
Artificial intelligence (AI) continues to reshape how clinical research is conducted, and a new framework called ...
Ensuring patients have access to the most accurate and up-to-date safety information is one of the FDA’s highest ...
Recent research suggests that artificial and low-/no-calorie sweeteners (LNCSs) might not be as harmless as many ...
The U.S. Food and Drug Administration (FDA) has finalized its long-awaited guidance on comparative analytical ...
In today’s globalized economy, pharmaceutical supply chains face mounting pressures. Natural disasters, ...
In today’s globalized economy, pharmaceutical supply chains face mounting pressures. Natural disasters, ...
The U.S. Food and Drug Administration (FDA) has taken regulatory action against two parties for significant ...
The U.S. Food and Drug Administration (FDA) had a busy week, marked by significant regulatory announcements, new ...
Chronic pain affects millions of Americans, and while opioids have long been a standard treatment, their risks of ...
Antibiotic resistance has long been recognized as one of the greatest challenges to global public health. While ...
No results found.